The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance

A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers

(2022) Li Yao et al.   NATURE BIOTECHNOLOGY

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma

(2021) Zaoqu Liu et al.   Journal of Translational Medicine

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma

(2021) Zaoqu Liu et al.   Frontiers in Oncology

Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer

(2021) Ben Liu et al.   Cell Death & Disease

Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1

(2021) Zaoqu Liu et al.   Frontiers in Oncology

Animal-eRNAdb: a comprehensive animal enhancer RNA database

(2021) Weiwei Jin et al.   NUCLEIC ACIDS RESEARCH

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma

(2020) Chuming Tao et al.   Frontiers in Oncology

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

(2020) Jinchul Kim et al.   Frontiers in Oncology

Histone demethylase JMJD1A inhibits proliferation and progression of gastric cancer by up‐regulating RUNX3

(2020) Ke Ning et al.   CANCER SCIENCE

Enhancer RNAs are an important regulatory layer of the epigenome

(2020) Vittorio Sartorelli et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture

(2020) Katla Kristjánsdóttir et al.   Nature Communications

Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures

(2019) Dongqiang Zeng et al.   Cancer Immunology Research

Cancer stemness, intratumoral heterogeneity, and immune response across cancers

(2019) Alex Miranda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The promise of Immuno-oncology: implications for defining the value of cancer treatment

(2019) Howard L. Kaufman et al.   Journal for ImmunoTherapy of Cancer

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

(2019) Yunhao Chen et al.   Molecular Cancer

HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer

(2019) Li Wei et al.   Human Cell

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer

(2019) Zhao Zhang et al.   Nature Communications

Random forest-based modelling to detect biomarkers for prostate cancer progression

(2019) Reka Toth et al.   Clinical Epigenetics

BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes

(2019) Yu-Li Chen et al.   Journal for ImmunoTherapy of Cancer

From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions

(2019) Manqing Wu et al.   Frontiers in Oncology

The immune landscape of esophageal cancer

(2019) Tu-Xiong Huang et al.   Cancer Communications

Functional Classification and Experimental Dissection of Long Noncoding RNAs

(2018) Florian Kopp et al.   CELL

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

(2018) Tathiane M. Malta et al.   CELL

Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies

(2018) Zhong-Yi Dong et al.   Journal of Thoracic Oncology

Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers

(2018) Timo M. Deist et al.   MEDICAL PHYSICS

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

(2018) Seung Tae Kim et al.   NATURE MEDICINE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

(2018) Sanjeev Mariathasan et al.   NATURE

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

(2018) Peng Jiang et al.   NATURE MEDICINE

Autologous dendritic cell-cytokine induced killer cell immunotherapy combined with S-1 plus cisplatin in patients with advanced gastric cancer: A prospective study

(2018) Guoliang Qiao et al.   CLINICAL CANCER RESEARCH

Global transcriptional activity dynamics reveal functional enhancer RNAs

(2018) Yoon Jung Kim et al.   GENOME RESEARCH

EMT and inflammation: inseparable actors of cancer progression

(2017) Meggy Suarez-Carmona et al.   Molecular Oncology

Elements of cancer immunity and the cancer–immune set point

(2017) Daniel S. Chen et al.   NATURE

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis

(2017) Xiuwen Lan et al.   OncoTargets and Therapy

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

(2017) Martin Lauss et al.   Nature Communications

Current status and perspectives in immunotherapy for metastatic melanoma

(2017) Riccardo Marconcini et al.   Oncotarget

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Microsatellite Instability

(2017) Liisa Chang et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

(2016) Willy Hugo et al.   CELL

Single-cell triple omics sequencing reveals genetic, epigenetic and transcriptomic heterogeneity in hepatocellular carcinomas

(2016) Yu Hou et al.   CELL RESEARCH

Microsatellite Instability as a Biomarker for PD-1 Blockade

(2016) J. C. Dudley et al.   CLINICAL CANCER RESEARCH

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

(2016) N. McGranahan et al.   SCIENCE

Epithelial-mesenchymal transition in glioblastoma progression

(2016) YASUO IWADATE   Oncology Letters

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade

(2016) Tavi Nathanson et al.   Cancer Immunology Research

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

(2015) Razvan Cristescu et al.   NATURE MEDICINE

HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families

(2015) Murali Janakiram et al.   OncoImmunology

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma

(2014) Jiagen Li et al.   GUT

Is microsatellite instability a prognostic marker in gastric cancer?: A systematic review with meta-analysis

(2014) Yoon Young Choi et al.   JOURNAL OF SURGICAL ONCOLOGY

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

(2014) Paul Geeleher et al.   PLoS One

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

(2014) C.-L. Hsieh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes

(2014) Nicholas E. Ilott et al.   Nature Communications

Tissue-Specific RNA Expression Marks Distant-Acting Developmental Enhancers

(2014) Han Wu et al.   PLoS Genetics

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

(2014) Paul Geeleher et al.   GENOME BIOLOGY

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

HER2-positive gastric cancer

(2013) Narikazu Boku   Gastric Cancer

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

(2011) Dong Wang et al.   NATURE

BEDTools: a flexible suite of utilities for comparing genomic features

(2010) Aaron R. Quinlan et al.   BIOINFORMATICS

Widespread transcription at neuronal activity-regulated enhancers

(2010) Tae-Kyung Kim et al.   NATURE

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

(2009) David A. Barbie et al.   NATURE